Martin Delaney Collaboratories for HIV Cure Research
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy
| Agency | National Institutes of Health |
|---|---|
| Status | Forecasted |
| Opportunity number | FOR-AI-27-001 |
| Posted date | 06/10/2025 |
| Estimated total funding | 20,000,000 |
| Expected number of awards | 6 |
| Assistance Listing (CFDA) | 93.855 |
| Description | The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy, with an ultimate goal of completely eradicating HIV reservoirs from the individual. The program will also address the unique needs of children living with HIV. The MDC program will accelerate HIV cure research by fostering strategic collaborations among academic institutions, scientists in government, the private sector, and community stakeholders. The program provides economies of scale by leveraging shared reagents, research resources, and specialized technologies in supp |
| Agency contact | diane.lawrence2@nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/359663 |